Market revenue in 2023 | USD 780.5 million |
Market revenue in 2030 | USD 1,352.7 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 64.69% in 2023. Horizon Databook has segmented the Latin America breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America includes Mexico and Brazil. Increase in the incidence of breast cancer and rapid economic development, especially in Mexico, are major factors expected to propel regional market growth over the forecast period. Although this region has high unmet patient needs, capitalization of market opportunities is difficult owing to the lack of appropriate healthcare infrastructure.
However, technological advancements are expected to contribute to market growth. Increase in government spending, presence of skilled healthcare professionals, rise in focus of multinational diagnostics companies to capture the untapped markets, and increase in patient awareness are expected to drive the market over the forecast period.
Moreover, increasing number of private–public partnerships to promote research on cancer targeted drugs development, along with rising R&D activities and funding for cancer research, is likely to contribute to market growth during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America breast cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account